Amundi »

Mersana Therapeutics shares owned by Amundi

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Amundi

Quarter filed Position value Share count Share price at filing
2023-12-31 $309k 96k 3.23

More positions owned by Amundi

Apple (AAPL)
Amazon Commstck (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Adobe Systems Incorporated (ADBE)
Advanced Micro Devices Commstck (AMD)
Stellantis SHS (STLA)
Home Depot (HD)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Mastercard Cl A (MA)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)

View all positions for Amundi

Top funds holding Mersana Therapeutics

EcoR1 Capital
VR Adviser
Balyasny Asset Management
Vanguard Group
Nextech Invest
Millennium Management
Citadel Advisors
5AM Venture Management
Schonfeld Strategic Advisors
Deutsche Bank Aktiengesellschaft
Baker Bros. Advisors
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of New York Mellon
Jane Street

View all funds holding Mersana Therapeutics